BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 10.24
-0.02 (-0.19%)
Aug 14, 2026, 5:02 PM CET
BioMaxima Market Cap
BioMaxima has a market cap or net worth of 42.94 million as of August 14, 2026. Its market cap has decreased by -22.72% in one year.
Market Cap
42.94M
Enterprise Value
58.64M
Revenue
59.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.24
ChartMarket Cap Chart
Since July 21, 2010, BioMaxima's market cap has increased from 11.40M to 42.94M, an increase of 276.52%. That is a compound annual growth rate of 8.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 42.94M | -15.02% |
| Dec 30, 2025 | 50.53M | 12.62% |
| Dec 30, 2024 | 44.87M | -34.84% |
| Dec 29, 2023 | 68.85M | -35.28% |
| Dec 30, 2022 | 106.38M | -6.37% |
| Dec 30, 2021 | 113.62M | -4.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.70B |
| NEUCA | 3.49B |
| Synektik Spólka Akcyjna | 3.07B |
| Voxel | 1.35B |
| Read-Gene | 58.83M |
| Genomtec | 57.85M |
| Milton Essex Spólka Akcyjna | 47.98M |
| Nestmedic | 41.50M |